DO
David C. Ott
David C. Ott
David C. Ott insider trades: Inhibrx Biosciences (INBX) stock buys and sales
Inhibrx Biosciences Last trade Oct 7, 2025 81 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
69
Open-market trades
since 2014
22
Companies
last trade 2025
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
INBXInhibrx Biosciences
Insider · last filing Oct 9, 2025
-$11.3M
+$55.9M
BBIOBridgeBio Pharma
Insider · last filing Jul 1, 2025
-$313.5M
+$160.0M
APGAPi Group
Insider · last filing Jun 18, 2024
-$764.0M
FDMT4D Molecular Therapeutics
Insider · last filing Jan 5, 2024
-$10.5M
+$38.9M
RYZBRayzeBio
Insider · last filing Feb 28, 2024
+$50.0M
ROIVRoivant Sciences
Insider · last filing Jun 26, 2023
-$257.4M
and 16 more companies
Open-market buys and sales
69 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | INBX | ↓ Sell | 350,000 | $32.25 | $11.3M | See Explanation of Responses | Oct 9, 2025 (2d) |
| Jun 27, 2025 | BBIO | ↓ Sell | 3,500,000 | $44.00 | $154.0M | See Explanation of Responses | Jul 1, 2025 (4d) |
| Jan 31, 2025 | BBIO | ↓ Sell | 3,065,616 | $34.90 | $107.0M | See Explanation of Responses | Jan 31, 2025 (0d) |
| Jun 17, 2024 | APG | ↓ Sell | 1,951,782 | $38.15 | $74.5M | See Explanation of Responses | Jun 18, 2024 (1d) |
| Jun 17, 2024 | APG | ↓ Sell | 1,951,782 | $38.15 | $74.5M | See Explanation of Responses | Jun 18, 2024 (1d) |
| Mar 5, 2024 | APG | ↓ Sell | 3,038,617 | $34.25 | $104.1M | See Explanation of Responses | Mar 7, 2024 (2d) |
| Mar 5, 2024 | APG | ↓ Sell | 3,038,617 | $34.25 | $104.1M | See Explanation of Responses | Mar 7, 2024 (2d) |
| Jan 4, 2024 | FDMT | ↓ Sell | 540,000 | $19.53 | $10.5M | See Explanation Responses | Jan 5, 2024 (1d) |
| Jan 2, 2024 | APG | ↓ Sell | 6,500,000 | $31.30 | $203.4M | See Explanation of Responses | Jan 4, 2024 (2d) |
| Jan 2, 2024 | APG | ↓ Sell | 6,500,000 | $31.30 | $203.4M | See Explanation of Responses | Jan 4, 2024 (2d) |
| Sep 19, 2023 | RYZB | ↑ Buy | 1,388,889 | $18.00 | $25.0M | See Explanation of Responses | Sep 21, 2023 (2d) |
| Sep 19, 2023 | RYZB | ↑ Buy | 1,388,889 | $18.00 | $25.0M | See Explanation of Responses | Sep 21, 2023 (2d) |
| Aug 28, 2023 | INBX | ↑ Buy | 511,627 | $19.35 | $9.9M | See Explanation of Responses | Aug 30, 2023 (2d) |
| Jul 18, 2023 | BBIO | ↓ Sell | 1,500,000 | $35.00 | $52.5M | See Explanation of Responses | Jul 19, 2023 (1d) |
| Jun 22, 2023 | ROIV | ↓ Sell | 13,000,000 | $9.90 | $128.7M | See Explanation of Responses | Jun 26, 2023 (4d) |
| Jun 22, 2023 | ROIV | ↓ Sell | 13,000,000 | $9.90 | $128.7M | See Explanation of Responses | Jun 26, 2023 (4d) |
| May 9, 2023 | FDMT | ↑ Buy | 850,000 | $16.00 | $13.6M | See Explanation Responses | May 11, 2023 (2d) |
| Nov 2, 2022 | FLAC | ↑ Buy | 847,062 | $10.08 | $8.5M | See Explanation of Responses | Nov 4, 2022 (2d) |
| Oct 7, 2022 | INBX | ↑ Buy | 1,333,333 | $30.00 | $40.0M | See Explanation of Responses | Oct 12, 2022 (5d) |
| Sep 9, 2022 | AMLX | ↓ Sell | 1,400,000 | $29.80 | $41.7M | See Explanation of Responses | Sep 9, 2022 (0d) |
| Mar 18, 2022 | PRCT | ↓ Sell | 1,249,000 | $29.90 | $37.3M | See Explanation of Responses | Mar 22, 2022 (4d) |
| Jan 11, 2022 | AMLX | ↑ Buy | 2,300,000 | $19.00 | $43.7M | See Explanation of Responses | Jan 13, 2022 (2d) |
| Sep 17, 2021 | PRCT | ↑ Buy | 400,000 | $35.00 | $14.0M | See Explanation of Responses | Sep 21, 2021 (4d) |
| Sep 3, 2021 | FIGS | ↓ Sell | 200,000 | $46.78 | $9.4M | See Explanation Responses | Sep 3, 2021 (0d) |
| Jul 29, 2021 | RLYB | ↑ Buy | 806,000 | $13.00 | $10.5M | See Explanation Responses | Aug 2, 2021 (4d) |
| Dec 15, 2020 | FDMT | ↑ Buy | 1,100,000 | $23.00 | $25.3M | See Explanation Responses | Dec 17, 2020 (2d) |
| Dec 14, 2020 | ADPT | ↓ Sell | 1,000,000 | $55.65 | $55.6M | See explanation of responses | Dec 16, 2020 (2d) |
| Dec 1, 2020 | ZNTL | ↓ Sell | 500,000 | $50.50 | $25.3M | See Explanation of Responses | Dec 3, 2020 (2d) |
| Nov 11, 2020 | ADPT | ↓ Sell | 2,500,000 | $49.52 | $123.8M | See explanation of responses | Nov 13, 2020 (2d) |
| Nov 11, 2020 | ADPT | ↓ Sell | 2,500,000 | $49.52 | $123.8M | See explanation of responses | Nov 13, 2020 (2d) |
| Aug 26, 2020 | INBX | ↑ Buy | 180,219 | $18.92 | $3.4M | See Explanation of Responses | Aug 28, 2020 (2d) |
| Aug 25, 2020 | INBX | ↑ Buy | 131,465 | $19.39 | $2.5M | See Explanation of Responses | Aug 25, 2020 (0d) |
| Apr 7, 2020 | ZNTL | ↑ Buy | 725,000 | $18.00 | $13.1M | See Explanation of Responses | Apr 8, 2020 (1d) |
| Jan 28, 2020 | ADPT | ↓ Sell | 4,912,899 | $24.98 | $122.7M | See explanation of responses | Jan 30, 2020 (2d) |
| Jan 28, 2020 | ADPT | ↓ Sell | 4,912,899 | $24.98 | $122.7M | See explanation of responses | Jan 30, 2020 (2d) |
| Jul 1, 2019 | ADPT | ↑ Buy | 250,000 | $20.00 | $5.0M | See explanation of responses | Jul 2, 2019 (1d) |
| Jul 1, 2019 | ADPT | ↑ Buy | 250,000 | $20.00 | $5.0M | See explanation of responses | Jul 2, 2019 (1d) |
| Jun 27, 2019 | BBIO | ↑ Buy | 4,705,900 | $17.00 | $80.0M | See Explanation of Responses | Jun 28, 2019 (1d) |
| Jun 27, 2019 | BBIO | ↑ Buy | 4,705,900 | $17.00 | $80.0M | See Explanation of Responses | Jun 28, 2019 (1d) |
| Jun 19, 2019 | UROV | ↑ Buy10b5-1 | 18,204 | $8.32 | $151K | Indirect | Jun 19, 2019 (0d) |
| Jun 19, 2019 | UROV | ↑ Buy10b5-1 | 18,204 | $8.32 | $151K | Indirect | Jun 19, 2019 (0d) |
| Jun 14, 2019 | UROV | ↑ Buy10b5-1 | 22,011 | $8.06 | $177K | Indirect | Jun 14, 2019 (0d) |
| Jun 14, 2019 | UROV | ↑ Buy10b5-1 | 22,011 | $8.06 | $177K | Indirect | Jun 14, 2019 (0d) |
| Jun 11, 2019 | UROV | ↑ Buy10b5-1 | 21,338 | $8.31 | $177K | Indirect | Jun 11, 2019 (0d) |
| Jun 11, 2019 | UROV | ↑ Buy10b5-1 | 21,338 | $8.31 | $177K | Indirect | Jun 11, 2019 (0d) |
| Jun 6, 2019 | UROV | ↑ Buy10b5-1 | 21,122 | $7.86 | $166K | Indirect | Jun 6, 2019 (0d) |
| Jun 6, 2019 | UROV | ↑ Buy10b5-1 | 21,122 | $7.86 | $166K | Indirect | Jun 6, 2019 (0d) |
| Jun 4, 2019 | MYOV | ↑ Buy | 2,424,242 | $8.25 | $20.0M | Indirect | Jun 13, 2019 (9d) |
| Jun 4, 2019 | MYOV | ↑ Buy | 2,424,242 | $8.25 | $20.0M | Indirect | Jun 13, 2019 (9d) |
| Jun 3, 2019 | UROV | ↑ Buy10b5-1 | 17,746 | $7.83 | $139K | Indirect | Jun 3, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INBX insiders
Open-market trades in the last 12 months
About David C. Ott's insider trades
David C. Ott is an insider at Inhibrx Biosciences (INBX). Since Nov 3, 2014, David has reported 47 open-market purchases worth $572.8M and 22 sales worth $2.02B on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (15 filings), other transactions (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.